FIELD: medicine.
SUBSTANCE: neuropathy pain is managed by introducing the compound selectively activating muscarine receptors subtype M(1) however not easing the acute pain.
EFFECT: possibility to manage neuropathy pain without reducing common stimulus sensory ability.
10 cl, 3 ex, 3 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MUSCARINIC RECEPTOR AGONISTS | 2015 |
|
RU2678835C2 |
| HETEROCYCLIC MUSCARINIC AGONISTS AND COMPOSITIONS, THEIR USING AND METHODS FOR TREATMENT | 2002 |
|
RU2292346C2 |
| PIPERAZINE DERIVATIVES, CHARACTERIZED BY MULTIMODAL ACTIVITY ON PAIN | 2014 |
|
RU2709482C1 |
| DERIVATIVES OF BENZIMIDAZOLIDINONE AS AGENTS FOR MUSCARINIC RECEPTORS | 2002 |
|
RU2288919C2 |
| NOVEL CLASS OF SELECTIVE AGONISTS OF SOMATOSTATIN RECEPTORS | 2014 |
|
RU2603962C2 |
| DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD | 2000 |
|
RU2293728C2 |
| AZOLE AND THIAZOLE DERIVATIVES AND USE THEREOF | 2006 |
|
RU2436779C2 |
| DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
| PIPERADINYL-SUBSTITUTED ISOQUINOLONE DERIVATIVES AS Rho-KINASE INHIBITORS | 2006 |
|
RU2414467C2 |
| IMIDAZOLYL PROGESTERONE ANTAGONISTS | 2014 |
|
RU2679445C2 |
